Endometriosis: 

Study: Pain Associated with Refractory Endometriosis

Description: A double-Blind, randomized ,controlled, multicenter, efficacy and safety study of study drug vs. placebo (each co-administered with combined oral contraceptive) assesing pain response in patients with refractory endometriosis

Entry Criteria:

• Females 18-49 premenopausal
• Surgical dx with Endo with in 5 years prior to screening
• Moderate to sever pelvic pain who response to at 2 months of prior therapy with GnRH agonist and at least on other hormonal therapy that have not had a surgical intervention for endo after they were recorded to have inadequately responded to GnRH agonist and at least one other hormal therapy

Study Duration: Participant will have 10 office visits over 36 weeks

Compensation: The Subject will receive all study related office visits, laboratory testing, and medication at no charge. Additionally the subject may be compensated for time and travel expenses up to $320.

Contact: Vicki Amole (727) 724-9730 vickia@xxresearch.com

Home | About | Products | News | Contact